Product Information
ACETAMINOPHEN ER 650 MG CAPLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0631 per EA under NDC 70010016001. Its NADAC has been published 192 times since Oct 26, 2022.
Strength
650 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010016001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA211544On Market Since
2/15/2022
Price Statistics
The NADAC for ACETAMINOPHEN ER 650 MG CAPLET has been published 192 times since Oct 26, 2022, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0631 per EA |
|---|---|
| All-time high | $0.0759 (Mar 15, 2023) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.0686 |
| 52-week low | $0.0631 |
| Median price | $0.0687 |
| Average price | $0.0683 |
| Largest weekly change | +16.2% (Feb 22, 2023) |
| Weeks tracked | 192 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ACETAMINOPHEN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN ER 650 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN ER 650 MG CAPLET, manufactured by Granules Pharmaceuticals Inc., is $0.0631 per EA (NDC 70010016001), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN ER 650 MG CAPLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN ER 650 MG CAPLET has declined 10.5%. It has been tracked across 192 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN ER 650 MG CAPLET?
Since Oct 26, 2022, the NADAC for ACETAMINOPHEN ER 650 MG CAPLET has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.0759 (Mar 15, 2023), with a median of $0.0687 per EA.
Are there cheaper alternatives to ACETAMINOPHEN ER 650 MG CAPLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ACETAMINOPHEN ER 650 MG CAPLET, so no direct lower-cost alternative is listed.
Who manufactures ACETAMINOPHEN ER 650 MG CAPLET?
ACETAMINOPHEN ER 650 MG CAPLET (NDC 70010016001) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification